Amneal Pharmaceuticals (AMRX) Stock Highlights

8.41 | -0.36%

2024-11-21 02:35:31

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The companys reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Statistics

Range Today

8.24 8.41

Volume Today 729.2K

Range 1 Year

4.16 9.48

Volume 1 Year 353.31M

Range 3 Year

1.24 9.48

Volume 3 Year 852.42M

Range 10 Year

1.24 24.48

Volume 10 Year 2.18B

Highlights

Market Capitalization 2.7B (mid)

Floating Shares 141.38M

Current Price 8.41

Price To Earnings -10.32

Price To Revenue 2.08

Earnings Per Share -0.79

Payout Ratio 0%

Performance

Latest -0.36%

1 Month -3.11%

3 Months +3.57%

6 Months +24.59%

1 Year +85.65%

3 Years +80.86%

5 Years +178.48%

10 Years -50.53%

Benchmarks

Market Capitalization

14 / 54

Gross Profits

8 / 39

Total Revenue

8 / 50

Total Rank

10 / 54

Free Cashflow

11 / 54

Performance 5 years

2 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.